Palisade Bio, Inc. (PALI) vs Treace Medical Concepts, Inc. (TMCI)
A side-by-side comparison of Palisade Bio, Inc. and Treace Medical Concepts, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
PALI
Palisade Bio, Inc.
$1.49HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TMCI
Treace Medical Concepts, Inc.
$4.00HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — PALI vs TMCI
growth of $100 · dividends reinvested · last 5yPALI -100.0% (-81.5%/yr)TMCI -82.5% (-29.4%/yr)TMCI compounded faster over this window
Log scale — wide-divergence pair
PALI TMCI
PALI vs TMCI: by the numbers
- •TMCI is the larger company ($259M vs $259M market cap).
- •Both run net losses; TMCI's is the smaller (-28.99% vs -6388.20% net margin).
Metrics side by side
Valuation
| Metric | PALI | TMCI |
|---|---|---|
| P/S ratio | 517.27 | 1.26 |
| P/B ratio | 2.12 | 3.83 |
Profitability
| Metric | PALI | TMCI |
|---|---|---|
| Gross margin | 0.00% | 79.45% |
| Operating margin | 0.00% | -26.17% |
| Net margin | -6388.20% | -28.99% |
| ROE | -26.24% | -87.86% |
| ROIC | -28.96% | -37.64% |
Growth (annualized)
| Metric | PALI | TMCI |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 21.44% |
| Total return CAGR (5Y) | -76.02% | -29.41% |
Frequently asked
- How have PALI and TMCI total returns compared?
- Over the past 5 years, PALI delivered -76.02% and TMCI delivered -29.41% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Palisade Bio ROETreace Medical Concepts ROEPalisade Bio operating marginTreace Medical Concepts operating marginPalisade Bio revenue growthTreace Medical Concepts revenue growthPalisade Bio free cash flowTreace Medical Concepts free cash flow
Palisade Bio & Treace Medical Concepts appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.